Report Detail

Pharma & Healthcare Global Neurodegenerative Diseases Market Professional Survey Report 2019

  • RnM3743383
  • |
  • 13 September, 2019
  • |
  • Global
  • |
  • 114 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    Executive Summary

      1 Industry Overview of Neurodegenerative Diseases

      • 1.1 Definition of Neurodegenerative Diseases
      • 1.2 Neurodegenerative Diseases Segment by Type
        • 1.2.1 Global Neurodegenerative Diseases Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 NMDA
        • 1.2.3 SSRIs
        • 1.2.4 Dopamine Inhibitors
      • 1.3 Neurodegenerative Diseases Segment by Applications
        • 1.3.1 Global Neurodegenerative Diseases Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Parkinson’s disease
        • 1.3.3 Huntington disease
        • 1.3.4 Amyotrophic Lateral Sclerosis
        • 1.3.5 Alzheimer’s disease
      • 1.4 Global Neurodegenerative Diseases Overall Market
        • 1.4.1 Global Neurodegenerative Diseases Revenue (2014-2025)
        • 1.4.2 Global Neurodegenerative Diseases Production (2014-2025)
        • 1.4.3 North America Neurodegenerative Diseases Status and Prospect (2014-2025)
        • 1.4.4 Europe Neurodegenerative Diseases Status and Prospect (2014-2025)
        • 1.4.5 China Neurodegenerative Diseases Status and Prospect (2014-2025)
        • 1.4.6 Japan Neurodegenerative Diseases Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Neurodegenerative Diseases Status and Prospect (2014-2025)
        • 1.4.8 India Neurodegenerative Diseases Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Neurodegenerative Diseases
      • 2.3 Manufacturing Process Analysis of Neurodegenerative Diseases
      • 2.4 Industry Chain Structure of Neurodegenerative Diseases

      3 Development and Manufacturing Plants Analysis of Neurodegenerative Diseases

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Neurodegenerative Diseases Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Neurodegenerative Diseases
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Neurodegenerative Diseases Production and Capacity Analysis
      • 4.2 Neurodegenerative Diseases Revenue Analysis
      • 4.3 Neurodegenerative Diseases Price Analysis
      • 4.4 Market Concentration Degree

      5 Neurodegenerative Diseases Regional Market Analysis

      • 5.1 Neurodegenerative Diseases Production by Regions
        • 5.1.1 Global Neurodegenerative Diseases Production by Regions
        • 5.1.2 Global Neurodegenerative Diseases Revenue by Regions
      • 5.2 Neurodegenerative Diseases Consumption by Regions
      • 5.3 North America Neurodegenerative Diseases Market Analysis
        • 5.3.1 North America Neurodegenerative Diseases Production
        • 5.3.2 North America Neurodegenerative Diseases Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Neurodegenerative Diseases Import and Export
      • 5.4 Europe Neurodegenerative Diseases Market Analysis
        • 5.4.1 Europe Neurodegenerative Diseases Production
        • 5.4.2 Europe Neurodegenerative Diseases Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Neurodegenerative Diseases Import and Export
      • 5.5 China Neurodegenerative Diseases Market Analysis
        • 5.5.1 China Neurodegenerative Diseases Production
        • 5.5.2 China Neurodegenerative Diseases Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Neurodegenerative Diseases Import and Export
      • 5.6 Japan Neurodegenerative Diseases Market Analysis
        • 5.6.1 Japan Neurodegenerative Diseases Production
        • 5.6.2 Japan Neurodegenerative Diseases Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Neurodegenerative Diseases Import and Export
      • 5.7 Southeast Asia Neurodegenerative Diseases Market Analysis
        • 5.7.1 Southeast Asia Neurodegenerative Diseases Production
        • 5.7.2 Southeast Asia Neurodegenerative Diseases Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Neurodegenerative Diseases Import and Export
      • 5.8 India Neurodegenerative Diseases Market Analysis
        • 5.8.1 India Neurodegenerative Diseases Production
        • 5.8.2 India Neurodegenerative Diseases Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Neurodegenerative Diseases Import and Export

      6 Neurodegenerative Diseases Segment Market Analysis (by Type)

      • 6.1 Global Neurodegenerative Diseases Production by Type
      • 6.2 Global Neurodegenerative Diseases Revenue by Type
      • 6.3 Neurodegenerative Diseases Price by Type

      7 Neurodegenerative Diseases Segment Market Analysis (by Application)

      • 7.1 Global Neurodegenerative Diseases Consumption by Application
      • 7.2 Global Neurodegenerative Diseases Consumption Market Share by Application (2014-2019)

      8 Neurodegenerative Diseases Major Manufacturers Analysis

      • 8.1 Novartis
        • 8.1.1 Novartis Neurodegenerative Diseases Production Sites and Area Served
        • 8.1.2 Novartis Product Introduction, Application and Specification
        • 8.1.3 Novartis Neurodegenerative Diseases Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Merck Serono
        • 8.2.1 Merck Serono Neurodegenerative Diseases Production Sites and Area Served
        • 8.2.2 Merck Serono Product Introduction, Application and Specification
        • 8.2.3 Merck Serono Neurodegenerative Diseases Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Teva Pharmaceutical
        • 8.3.1 Teva Pharmaceutical Neurodegenerative Diseases Production Sites and Area Served
        • 8.3.2 Teva Pharmaceutical Product Introduction, Application and Specification
        • 8.3.3 Teva Pharmaceutical Neurodegenerative Diseases Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 UCB
        • 8.4.1 UCB Neurodegenerative Diseases Production Sites and Area Served
        • 8.4.2 UCB Product Introduction, Application and Specification
        • 8.4.3 UCB Neurodegenerative Diseases Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Pfizer
        • 8.5.1 Pfizer Neurodegenerative Diseases Production Sites and Area Served
        • 8.5.2 Pfizer Product Introduction, Application and Specification
        • 8.5.3 Pfizer Neurodegenerative Diseases Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Biogen Idec
        • 8.6.1 Biogen Idec Neurodegenerative Diseases Production Sites and Area Served
        • 8.6.2 Biogen Idec Product Introduction, Application and Specification
        • 8.6.3 Biogen Idec Neurodegenerative Diseases Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Bayer Schering Pharma AG
        • 8.7.1 Bayer Schering Pharma AG Neurodegenerative Diseases Production Sites and Area Served
        • 8.7.2 Bayer Schering Pharma AG Product Introduction, Application and Specification
        • 8.7.3 Bayer Schering Pharma AG Neurodegenerative Diseases Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Boehringer Ingelheim
        • 8.8.1 Boehringer Ingelheim Neurodegenerative Diseases Production Sites and Area Served
        • 8.8.2 Boehringer Ingelheim Product Introduction, Application and Specification
        • 8.8.3 Boehringer Ingelheim Neurodegenerative Diseases Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Addex Pharmaceutical
        • 8.9.1 Addex Pharmaceutical Neurodegenerative Diseases Production Sites and Area Served
        • 8.9.2 Addex Pharmaceutical Product Introduction, Application and Specification
        • 8.9.3 Addex Pharmaceutical Neurodegenerative Diseases Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Amarin
        • 8.10.1 Amarin Neurodegenerative Diseases Production Sites and Area Served
        • 8.10.2 Amarin Product Introduction, Application and Specification
        • 8.10.3 Amarin Neurodegenerative Diseases Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 AstraZeneca
      • 8.12 Asubio Pharmaceutical
      • 8.13 Bial
      • 8.14 Alector
      • 8.15 Yumanity Therapeutics
      • 8.16 Eisai
      • 8.17 H.Lundbeck A/S
      • 8.18 Jiangsu Hansoh Pharmaceutical
      • 8.19 Yangtze River Pharmaceutical Group
      • 8.20 Chongqing Zein Pharmaceutical

      9 Development Trend of Analysis of Neurodegenerative Diseases Market

      • 9.1 Global Neurodegenerative Diseases Market Trend Analysis
        • 9.1.1 Global Neurodegenerative Diseases Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Neurodegenerative Diseases Regional Market Trend
        • 9.2.1 North America Neurodegenerative Diseases Forecast 2019-2025
        • 9.2.2 Europe Neurodegenerative Diseases Forecast 2019-2025
        • 9.2.3 China Neurodegenerative Diseases Forecast 2019-2025
        • 9.2.4 Japan Neurodegenerative Diseases Forecast 2019-2025
        • 9.2.5 Southeast Asia Neurodegenerative Diseases Forecast 2019-2025
        • 9.2.6 India Neurodegenerative Diseases Forecast 2019-2025
      • 9.3 Neurodegenerative Diseases Market Trend (Product Type)
      • 9.4 Neurodegenerative Diseases Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Neurodegenerative Diseases Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Neurodegenerative diseases are becoming increasingly prevalent due to an aging population, but this diverse therapy area remains largely untreatable with current therapies. Neurodegenerative diseases are characterized by neuronal death within the brain and/or central nervous system (CNS), leading to progressive decline in functional neurological capacities. It has a devastating effect on quality of life and independence, often requiring full-time care during the later disease stages.

        The global Neurodegenerative Diseases market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Neurodegenerative Diseases volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neurodegenerative Diseases market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Neurodegenerative Diseases in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Neurodegenerative Diseases manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Novartis
        Merck Serono
        Teva Pharmaceutical
        UCB
        Pfizer
        Biogen Idec
        Bayer Schering Pharma AG
        Boehringer Ingelheim
        Addex Pharmaceutical
        Amarin
        AstraZeneca
        Asubio Pharmaceutical
        Bial
        Alector
        Yumanity Therapeutics
        Eisai
        H.Lundbeck A/S
        Jiangsu Hansoh Pharmaceutical
        Yangtze River Pharmaceutical Group
        Chongqing Zein Pharmaceutical

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        NMDA
        SSRIs
        Dopamine Inhibitors

        Segment by Application
        Parkinson’s disease
        Huntington disease
        Amyotrophic Lateral Sclerosis
        Alzheimer’s disease


        Summary:
        Get latest Market Research Reports on Neurodegenerative Diseases. Industry analysis & Market Report on Neurodegenerative Diseases is a syndicated market report, published as Global Neurodegenerative Diseases Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Neurodegenerative Diseases market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,716.68
        4,075.01
        5,433.35
        3,173.23
        4,759.85
        6,346.47
        380,380.00
        570,570.00
        760,760.00
        251,267.45
        376,901.18
        502,534.90
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report